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Background: Triatoma infestans, the main vector of Trypanosoma cruzi (causative agent of Chagas disease) has
been successfully eliminated over much of its original geographic distribution over the southern cone countries of
South America. However, populations of the species are still infesting houses of rural communities of the Gran
Chaco region of Argentina and Bolivia. This study reports for the first time a large-scale effect of a vector control
intervention using a microencapsulated formulation of organophosphates and insect growth regulator on house
infestation by T. infestans, in the southwestern region of Santa Cruz de la Sierra Department, within the Bolivian
chaco.
Methods: The vector control intervention included the treatment and entomological evaluation of 1626 individually
coded and georeferenced houses with the microencapsulated formulation. House infestation by T. infestans was
evaluated by active searches with fixed capture effort carried out before and after two, 16 and 32 months of the
treatment application.
Results: House infestation prevalence was 30.5% before the intervention, spatially aggregated in two clusters of 38 and
25 localities that showed 41% and 38% house infestation by T. infestans. Infestation prevalence was reduced to 2.4%
two months after the intervention and remained very low (1.7%) until the end of the study after 32 months of the
control intervention, without any other additional vector control intervention.
Conclusions: The obtained results show an important long lasting effect on house protection against triatomine
infestation in a region of known pyrethroid resistant populations of T. infestans, as the result of the slow release of the
active ingredients, protected by the formulation microcapsule.
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Chagas disease, produced by the infection of Trypano-
soma cruzi, is one of the main endemic diseases of Latin
American countries, affecting about seven million people
[1]. T. cruzi is transmitted to mammals by haematopha-
gous insect vectors of the Triatominae subfamily (Redu-
viidae). It is considered that all Triatominae species are
able to transmit the parasite, although less than 10 of
the species have epidemiological importance, because of
their association with humans. More than 90% of the
Triatominae species occur in the Americas, with a small* Correspondence: david.gorla08@gmail.com
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unless otherwise stated.group occurring in Asia (China, India and northern
Australia) [2]. T. cruzi is mainly transmitted by the tria-
tomine vectors in the Americas, the transmission route
is via their faeces eliminated after a blood meal onto the
human body or through the consumption of food con-
taminated by insect faeces. T. cruzi can also be transmit-
ted in the absence of insect vectors by the congenital
route, through uncontrolled blood transfusions and
organ transplants, or laboratory accidents with contami-
nated material. Initially restricted to the Americas, Chagas
disease is now globally distributed because of human mi-
gration, especially in the USA (where about 300,000
people are infected) and Europe (where nearly 90,000
people are affected, especially located in Spain) [3,4].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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coupled with a reduction of the rural population that
migrated to urban environments and a generalized im-
provement in the living standard of rural communities
(with exceptions), has successfully reduced the burden
of the Chagas disease in Latin American countries. Wide
areas of South and Central America are now certified by
the Pan American Health Organization (PAHO) as hav-
ing interrupted the transmission of T. cruzi by alloctho-
nous triatomine vectors and by blood transfusion, within
the framework of the continental initiatives for the con-
trol of Chagas disease. The Southern Cone was the first
of the initiatives (INCOSUR) that started in 1991 and
coordinated efforts to interrupt T. cruzi transmission
through blood transfusion and by Triatoma infestans,
the species that once accounted for more than 50% of
the Chagas disease vectorial cases in America. Bolivia
was the last of the Southern Cone countries to create a
national programme to control Chagas disease. The sys-
tematic effort that started towards 2000 resulted in a
strong reduction of the new infections, especially in the
Altiplano region, where PAHO certified the interruption
of the vectorial transmission of T. cruzi by T. infestans
in the La Paz Department [5].
Although very successful in the Southern Cone of Latin
America, the control of T. infestans is not complete in the
Gran Chaco region (that covers western Paraguay, north-
western Argentina and eastern Bolivia), where T. cruzi is
still actively transmitted in hot spot areas with high preva-
lence of house infestation and high abundance of T. infes-
tans populations. A number of concurrent factors were
mentioned as preventing the successful control of T. infes-
tans populations infesting houses of rural communities of
the Gran Chaco. Among these factors, the unsustained
systematic vector control interventions derived from in-
stabilities of health policies, the very low efficacy of sus-
pension concentrate pyrethroid formulation to eliminate
T. infestans populations infesting peridomestic structures
[6] and the occurrence of pyrethroid resistant populations
of T. infestans were mentioned [7-9].
After the recognition of low efficacy of the suspension
concentrate formulations of pyrethroids to control T.
infestans populations in the Gran Chaco, alternatives
were analysed after studies were carried out under labora-
tory and/or field conditions. These alternatives included
the study of active ingredients different to pyrethroids
and/or alternatives to the traditional suspension concen-
trate formulation, as imidachloprid [10], and cypermethrin
for dog collars [11,12], fipronil as a ‘spot on’ [13,14], and
cypermethrin as a ‘pour on’ formulation [15-17]. Habitat
modification and biological control have also been studied
as reported for the modification of peridomestic structures
[18], and biological control agents (oophagous parasitoids
[19], fungi [20], and virus [21]). Among the studiedalternatives, the microencapsulated organophosphate for-
mulations were the only one evaluated under field condi-
tions and not only at the experimental scale but using big
sample size interventions; the formulation is prepared as a
base paint that can be combined with colour to give the
house a nice appearance [22].
The objective of the study is to report on the effect of
a microencapsulated formulation of organophosphate in-
secticides on the infestation by T. infestans in rural
houses of the Bolivian Chaco. Although the treatment of
houses was not specifically planned for the present ob-
jective, the existing situation was used to design the ana-
lysis of the results as an observational study based on
the time since the houses received the treatment, to




The vector control intervention included houses distrib-
uted in 96 localities of the municipalities of Cuevo and
Lagunillas (Santa Cruz Department, Bolivia) (Figure 1).
The treatment of houses was carried out two weeks after
the following base line study (see below). A total of 1626
houses were treated, out of the 2197 houses in the re-
gion. Houses left untreated were either good quality
ones in bigger towns or closed ones. The geographic co-
ordinate of each house was recorded with handheld GPS
receivers and received an individual code number that
was used to carry out the followup along the study
period.
The intervention was part of a project supported by
the Generalitat Valenciana (Spain) that aimed at improv-
ing the living conditions of the rural communities, and
was based on the application of a microencapsulated or-
ganophosphate formulation (Inesfly 5A IGR), containing
diazinon, chlorpyriphos and the insect growth regulator
pyriproxyfen (details of the formulation in [23], included
in microcapsules that allow the slow liberation of the ac-
tive ingredients from the treated surfaces.
The microencapsulated formulation was applied using a
Jacto manual pump (HD-400 model, with nozzle JD-12P)
to the internal and external walls, roof and all peridomes-
tic structures (especially goat corrals, chicken coops and
grain and tool deposits).
Study design
The study included an entomological evaluation of the
house infestation by T. infestans before intervention
(base line survey) and another three entomological evalua-
tions two, sixteen and thirty two months after the vector
control intervention. Standard post-intervention timing
for the evaluation of a pyrethroid insecticide against tria-
tomines is one, six, and 12 months [24]. Because the
Figure 1 Location of the 96 localities (white circles) of the study area. Radius of circles are proportional to the number of houses in each
locality. Red circles indicate localities within the north and south cluster of high house infestation by Triatoma infestans. Inset shows the study
area location, south of Santa Cruz de la Sierra (Bolivia).
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than the usual time needed to apply suspension concen-
trate formulations, the first entomological evaluation was
carried out on average two months after the intervention.
Knowing the longer lasting effect of the microencapsu-
lated formulation under laboratory conditions [23], the
posterior entomological evaluations were carried out 16
and 32 months after the intervention.
The entomological evaluations (either before or after
the intervention) were carried out by agents of the Santa
Cruz de la Sierra health authority (SEDES Santa Cruz),
and consisted of timed active searches by a two-person
team that made a 15-minute search within the house
and another 15-minute search on the peridomestic
structures, an adopted standard by the Pan American
Health Organization for all Subregional Initiatives against
vectors of Trypanosoma cruzi. T. infestans specimens
were categorized as nymphs and adults, and identified by
collection site (roof or walls in the intradomicile, and goat
corral, chicken coop and grain and tools deposit in theperidomicile). House infestation prevalence was catego-
rized as intradomestic (ID) or peridomestic (PD) and cal-
culated as number of houses with T. infestans divided by
the number of evaluated houses in the ID or PD. Insect
density was calculated as number of collected insects by
evaluated house or by infested house.
Base line data were collected through an entomo-
logical evaluation of T. infestans house infestation in
1712 houses, between November 2006 and May 2007.
Of the 1712 evaluated houses, 1626 were treated with
the microencapsulated formulation. The previous vector
control intervention with insecticide (alfacypermethrin)
in the study area, prior to the baseline survey was car-
ried out in 2003.
Following the application of the microencapsulated
formulation, a first entomological evaluation was carried
out after two months (between March and July 2007). A
second entomological evaluation was carried out 16 months
after the treatment (between May and July 2008), and the
third entomological evaluation (data available only for
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the intervention, between May and October 2009. Table 1
synthesizes the number of treated houses and houses eval-
uated on each occasion during the studied period. The
number of houses evaluated varied on each occasion, as
owners were not always present and/or were not inter-
ested in participating in the project. House infestation
prevalence (either ID or PD) was calculated as the number
of infested houses divided by the number of houses evalu-
ated on each occasion. Insect density is reported as an
average per evaluated house and average per infested
house.
Data analysis
Comparison of house infestation prevalence was carried
out calculating odds ratios. Comparison of T. infestans
density among sampling dates was carried out through
the estimation of a generalized linear model (glm func-
tion) with a Poisson link and the multiple comparison
for glm (glht function) of the R package [25]. The detec-
tion of the spatial aggregation (clusters) of house infest-
ation was based on each house coordinate and carried
out using the ScanStat statistics [26], as described by
[27]. Each cluster is defined as a group of localities that
shows a significatively higher infestation than the aver-
age infestation prevalence in the area.
Results
Houses were highly dispersed, with 62.9% of the local-
ities having 60 or fewer houses. Of the total number of
2197 houses existing in the region, 36.2% were located
in three localities having between 140 and 435 houses.
Smaller villages had higher treatment coverage; 87% of
houses were treated in villages with less than 100 houses,
whereas 70% of them were treated in villages with more
than 100 houses.
The base line entomological evaluation (before the
intervention) showed that 17.9% (out of a total of 1712
evaluated houses) had intradomestic infestation, 17.3%
had peridomestic infestation, and 4.8% had intra and
peridomestic infestation, making an overall infestation of
either intra and/or peridomestic infestation of 30.5%.Table 1 House infestation by T. infestans before and after the
No of houses
Months after intervention Evaluated (infested) Painted (infested
0 (BL) 1712 (522) 1626 (502)
2 (E1) 1947 (52) 1529 (46)
16 (E2) 2096 (49) 1572 (32)
32 (E3) 1064 (19) 1012 (18)
ID and PD: number of evaluated and infested houses in intradomestic and peridom
microencapsulated application (baseline); E1, E2 and E3 are entomological evaluatio
ratio (OR) and 95% confidence interval (CI95%) contrasts infestation prevalence at B
(E1, E2, E3).The infestation was widespread, showing a dispersion
index of 68.8% (66 out of 96 localities). The spatial ana-
lysis of house infestation showed there was significant
aggregation of infested houses in two clusters. There
was one cluster north of the study area with 38 localities,
this included 451 houses, had 41.0% infestation, and
there was another cluster south of the study area with
25 localities and 375 houses that had 38.4% infestation
compared with 11.8% infestation outside the clusters, in
1221 houses of 33 localities (Figure 1).
Before the house treatment, average abundance (ID
and PD) was 2.2 insects per evaluated house. It was sig-
nificantly higher in chicken coops (5.9 insects/positive
site) than in other sites (P < 0.05) and showed no differ-
ence between high infestation cluster localities and out-
side the cluster (P > 0.05) (Table 2).
Two months after the microencapsulated formulation
application, the aggregation of house infestation found
in the base line study disappeared, i.e. no significant
spatial cluster was identified. Intradomestic infestation
was found in 13 houses, whereas peridomestic infest-
ation was found in 39 (0.7% and 2.0% house infestation
prevalence, respectively) (Table 1). Intradomestic infest-
ation was found mainly in room walls (10 cases out of
13) and chicken coops (24 cases out of 39). Average
intradomestic density was 6.4 insects per infested house
and average peridomestic density was 5.3 per infested
house. Overall insect density average (intra and perido-
mestic), considering the 1947 evaluated houses was 0.2
insects per house, a 11.4-fold reduction compared with
the base line study (Table 2).
The entomological evaluation carried out sixteen
months after the microencapsulated formulation appli-
cation, showed that a group of 49 houses (2.3%) were
infested in the intra and/or peridomestic structures (out
of 2096 evaluated) and a significant (P = 0.04) small ag-
gregation of high infestation appeared south of the high
infestation aggregation detected during the base line
study. The aggregate included eight infested houses
within a group of nine localities that comprised 122
houses (6.6% intradomestic infestation within the cluster,
compared with and infestation of 0.8% outside it) (Table 1).intervention with the microencapsulated formulation
Infested houses Collected insects OR (CI 95%)
) ID PD ID PD
307 297 1459 2345
13 39 83 297 0.071 (0.052; 0.096)
24 49 77 195 0.047 (0.033; 0.068)
8 11 30 51 0.039 (0.024; 0.063)
estic structures. BL is the entomological evaluation of houses before the
ns after 2, 12 and 32 months after the microencapsulated application. Odds
L, with entomological evaluations after the microencapsulated application
Table 2 Triatoma infestans density per infested house (D1) and per evaluated house (D2) in intradomestic and peridomestic
sites, within (C) and outside (NC) of high infestation localities cluster (identified at the baseline entomological evaluation)
Intradomestic Peridomestic
Wall Roof Deposit Wall Chicken coops Corrals
LB C D1 4.83 (5.69; 95) 3.25 (3.86; 4) 3.78 (3.3; 18) 5.04 (5.52; 24) 10.16 (16.69; 61) 7.4 (7.83; 5)
D2 0.72 (2.78; 638) 0.02 (0.37; 638) 0.11 (0.83; 638) 0.19 (1.42; 638) 0.97 (5.93; 638) 0.06 (0.9; 638)
NC D1 4.43 (3.99; 155) 3.33 (2.52; 3) 4.34 (4.09; 35) 6.33 (6.12; 75) 9.19 (10.45; 123) 1.88 (1.22; 17)
D2 0.59 (216; 1160) 0.01 (0.2; 1160) 0.13 (1.02; 1160) 0.41 (2.2; 1160) 0.97 (4.42; 1160) 0.03 (0.27; 1160)
E1 C D1 13 (13.75; 3) 0 22 (; 1) 7 (; 1) 6.64 (6.42; 11) 0
D2 0.06 (1.16; 654) 0 0.03 (0.86; 654) 0.01 (0.27; 654) 0.11 (1.17; 654) 0
NC D1 2.57 (1.51; 7) 0 2.5 (; 2) 0 4.65 (2.65; 24) 0
D2 0.01 (0.22; 1293) 0 0.003 (0.09; 1293) 0.01 (0.35; 1293) 0.08 (0.78; 1293) 0
E2 C D1 2.00 (0.63; 6) 0 2 (; 1) 8 (; 1) 2.4 (2.15; 5) 0
D2 0.02 (0.2; 667) 0 0.003 (0.08; 667) 0.01 (0.31; 667) 0.02 (0.27; 667) 0
NC D1 3.81 (5.47; 16) 0 0 3.75 (0.96; 4) 11.07 (16.37; 14) 1 (; 2)
D2 0.04 (0.67; 1429) 0 0 0.01 (0.20; 1429) 0.11 (1.84; 1429) 0.001 (0.06; 1429)
Entomological evaluations: base line (LB), 2 months (E1) and 12 months (E2) after the application od the microencapsulated formulation. D1 figures represents
overall insect density average per. infested house (standard deviation; number of infested houses); D2 figures represents density. average per evaluated house
(standard deviation; number of evaluated houses). Standard deviation is calculated for n>2.
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per infested house within and outside the high infestation
aggregation, respectively. The most frequent sites of insect
capture were chicken coops and room walls (Table 2).
In the entomological evaluation carried out thirty-two
months after the microencapsulated formulation appli-
cation, house infestation prevalence was 1.78% intra
and/or peridomestic infestation (Table 1). Average dens-
ity was 3.7 and 4.6 insects per infested house in the intra
and peridomestic structures. Overall insect density was
very low: 0.03 and 0.05 in the intra and peridomestic
structures, representing a 27 and 11-fold reduction, re-
spectively, compared with the baseline study. The most
frequent sites of insect capture were chicken coops and
room walls (Table 2).
Overall insect density (per evaluated house) decreased
significantly (P < 0.001) after the microencapsulated ap-
plication, maintaining very low values throughout the
study period. Insect density per infested house main-
tained similar values along the study period (P > 0.05).
Discussion
Vector control programmes in Latin American countries
have successfully interrupted the vectorial transmission
of T. cruzi in several areas of South and Central America.
Control programmes of Chagas disease vectors started
in the 1950’s and 1960’s as well structured institutions in
Argentina, Brasil and Venezuela, but appeared later in
other countries, like Bolivia. After some decades of under-
funded and irregular activities, the National Programme
of Chagas Disease in Bolivia started by the early 2000s a
new institutional cycle of systematic activities that showedthe most important impact over the disease [28]. Import-
ant advances on the vector control interventions in the
Andean Valleys were obtained, although the region of the
Bolivian Chaco still shows rural communities with a high
proportion of houses infested by T. infestans, similar to
the situation occurring in a number of areas in the Gran
Chaco region of Argentina. Several reasons have been in-
voked to account for the failure of vector control interven-
tions in the Gran Chaco region of Argentina, Bolivia and
(at a minor extent) Paraguay. Among them, political in-
stabilities and fund shortage, low efficacy of pyrethroid in-
secticides and pyrethroid resistance [6,29].
One of the reasons for the low efficacy of the vector
control interventions in the Bolivian Chaco became clear
after 2001, when the existence of T. infestans popula-
tions resistant to pyrethroids was identified in northern
Argentina and then in several areas within the Bolivian
Chaco [29]. Resistance to pyrethroid insecticides of sev-
eral studied T. infestans populations is high or very high
[30], and resistance to other active ingredients (e.g.
fipronil) never used for vector control in the area has
also been found. This situation is attributed to the high
genetic variability of the T. infestans populations occur-
ring in the area that is associated with the centre of ori-
gin from which the species expanded to occupy most of
the southern cone of South America [31-33]. Two add-
itional reasons (and probably more extended than in-
secticide resistance) were identified as causing the low
efficacy of pyrethroid insecticides for the control of tria-
tomines in the Gran Chaco region. One is the rapid deg-
radation of the active ingredient molecules caused by
UV light, giving a residual activity of no more than two
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mine population in the complex peridomestic structures
usually present in the rural communities of the Gran
Chaco [27].
This study is the first carried out in Bolivia using indi-
vidualized coding for individual houses and the first to
report the effect of a vector control intervention using a
microencapsulated formulation of organophosphates
over the infestation by Triatoma infestans, the main vec-
tor of Trypanosoma cruzi in the southern cone countries
of South America. As found in other areas [27], house
infestation prevalence showed significant spatial aggrega-
tion before the control intervention in the base line
entomological evaluation of the present study. House in-
festation prevalence aggregation is usually promoted
(among other factors) by the house quality, and this might
be the aggregation cause in this case. The spatial aggrega-
tion of house infestation was not detected on the three en-
tomological evaluations after the control intervention.
Although not tested directly, recent reports suggest
that some T. infestans populations occurring in the study
area are resistant to pyrethroids [8]. Even under this
difficult scenario that pose difficult vector control situa-
tions in other areas where suspension concentrate for-
mulations of pyrethroids are used, the intervention using
the microencapsulated formulation maintained a very
good control level, keeping the house infestation below
1.8% after 32 months of the house treatment, without
the addition of any other vector control intervention.
The microencapsulated formulation produces a longer
effect on the T. infestans population mortality than that
observed after the application of the traditional pyrethroid-
based suspension concentrate formulation, that in the ab-
sence of additional control measures allow the recovery of
the original T. infestans population abundance between
one-three years after the intervention [34,35]. The con-
trast between formulations is attributed to the mechanism
of slow release from the microencapsulated formulation
[23] and to the protection that the microcapsules offer on
the active ingredients, that normally is rapidly degraded
because of the effect of environmental factors (UV, surface
porosity, high temperatures) as shown by [6]. A similar
long lasting effect of the organophosphate microencapsu-
lated formulation on a nearby region of Santa Cruz and
Tarija Departments (Bolivia) was reported in a study by
[36], where they showed 22% mortality of locally collected
fifth instar nymphs and adult T. infestans after wall bio-
assays on houses treated 34 months before. The same
microencapsulated formulation, either based on or-
ganophosphate or pyrethroid active ingredients showed
successful control on a number of insect pests, like
pyrethroid-resistant mosquitoes [37,38], a palm pest
curculionid [39], ants [40] and tsetse flies in Cote
d’Ivoire [41].Findings of this study should be considered within the
limitations imposed by its own design. As there is no
control group, we can not attribute the effect of the mi-
croencapsulated formulation as the unique cause for the
elimination of T. infestans house infestation, as the out-
come might be combined with effects derived from a be-
havioural change of the rural communities that kept
rooms clean and tidy, or because vectors were easier to
detect (and kill) against a recently painted wall. However,
all past published evidence suggest that the microencap-
sulated formulation is at least and by far the most im-
portant driving cause of T. infestans reduction in the
intervened communities.
The cost of the vector control intervention using the
microencapsulated formulation is about 120 US dollars,
for an average house with 300–320 square meters. Con-
sidering the longer lasting effect, the figure is below the
cost of the standard intervention using pyrethroid insec-
ticides, that ranges between 25 and 65 U$ per house
[42,43] respectively. Inflation adjusted dollars to a 1999
common base give 85.8, 35.2, 67.5 (calculated through
https://cps.ipums.org/cps/cpi99.shtml) for the microen-
capsulated formulation, lower and upper extremes of
pyrethroid-based intervention, respectively.
For the case of domestic triatomine control, besides
the long lasting effect, the microencapsulated formula-
tion has an additional advantage over other formula-
tions, as it can be applied as a wall paint with colour
selected by the house owner. Although perceived as a
minor element at the beginning of the vector control
intervention, it came out as an important factor for the
subsequent effect on triatomine recolonization. As house
owners perceived the embellished house as a nicer place
to live in, they were keener on maintaining house clean-
liness and order, thus decreasing the chance of a reinfes-
tation by triatomines [22].
Conclusions
This study, carried out in the Bolivian Chaco (southwest
Santa Cruz de la Sierra Department), shows that a mi-
croencapsulated formulation carrying organophosphates
and insect growth regulator as active ingredients is cost-
effective for the reduction of house infestation preva-
lence by T. infestans and the maintenance of the low
prevalence figures (<2% after 32 months of the vector
intervention) for a longer period than equivalent vector
control interventions based on suspension concentrate
formulations applied with spraying pumps.
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